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ABSTRACT 
Advisors Dr. Monica Frazier and Dr. Kathleen Hughes 
We studied the effects of curcumin on the proliferation and viability of MDA-MB-468 
breast cancer cells and its effects on the expression of Bcl-2 and p53 proteins in these cells. 
Based on previous studies, we predicted a dose-dependent increase in p53 (tumor suppressor) 
expression, and a decrease in Bcl-2 (anti-apoptotic oncoprotein) expression. Briefly, MDA-MB- 
468 cells were seeded into 12-well plates at 2.0 * 104 cells/well and allowed to grow for 72 hrs. 
Cells were treated with curcumin at 0, 25, 50 and 100 pM in triplicate at time zero and cultured 
for another 24 hours. All data were obtained using a Muse Cell Analyzer. Proliferation and 
viability data were determined using an Annexin V and Dead Cell Kit, p53 expression was 
determined using a Multi-Colored DNA Damage Kit, and Bcl-2 expression was determined 
using a Bcl-2 Activation Dual Detection Kit. Results show a significant dose-dependent increase 
in both cell death and proliferation. However, there was no significant difference in expressions 
of both p53 and Bcl-2 oncoproteins across the four treatments. Future studies will investigate 
additional mechanisms by which curcumin induces these apoptotic effects. 
INDEX WORDS: Apoptosis, bcl-2 protein, curcumin, p53 protein. 
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Chapter I 
Introduction 
1.1.1 Breast Cancer 
Recent statistics show that breast cancer is the most common and the second leading 
cause of malignancy-related deaths among women worldwide (Crawford and Richard, 2013; 
Jemal et al, 2011). In the United States alone, more than 200,000 new cases are diagnosed 
annually and approximately 40,000 deaths occur as a result of this malignancy (Crawford and 
Richard, 2013; Jemal et al., 2011). 
Cancer occurs when cells begin to proliferate uncontrollably due to genetic mutations 
and/or abnormal proliferation signals (Watts, 2013). During puberty, the hormone estrogen 
signals the development of breast tissue and the hormone progesterone stimulates the growth of 
lobular tissue (BreastCancer.org, Watts, 2013). When abnormal cell growth arises in ductal 
breast tissue, it is termed ductal carcinoma in situ, DCIS and when abnormalities occur in lobular 
tissue, it is termed lobular carcinoma in situ, LCIS (BreastCancer.org, Watts, 2013). Breast 
cancer onset can take a few years, beginning with a cluster of cells that are unable to follow the 
"rules" of the cell cycle progression, to a later accumulation of increased mutations that make 
these cells capable of unrestricted proliferation (BreastCancer.org). 
1.1.2 Curcumin 
Curcumin, the active ingredient of turmeric (curry spice), is believed to be 
associated with reduced incidence rates of breast cancer among women in Southeast Asian 
countries (Nagaraju et al. 2012). Curcumin (diferuloylmethane) is a yellow-colored polyphenol 
that is extracted from the Curcuma longa plant, commonly known as turmeric (Liu and Chen, 
2013; Welkin et al., 2011). It has been consumed as a dietary spice for centuries and has played a 
key role in Ayurvedic medicine. Curcumin is known to possess a variety of beneficial and 
therapeutic properties such as anti-oxidant, anti-inflammatory, anti-metastatic and anti- 
proliferative activities (Liu and Chen, 2013; Wilken et al., 2011). Recent studies have also 
proven curcumin's anti-cancer properties via its suppression of gene products such as c-myc, 
Bcl-2, and interleukins, its target of biological pathways, inhibition of growth factors, 
transcription factors and cell adhesion molecules involved in mutagenesis, cell cycle regulation, 
gene expression, apoptosis, metastasis, and tumorigenesis (Wilken et al., 2011, Liu and Chen 
2013; Cine et al., 2013). 
1.1.3    p53 protein and cancer 
The tumor suppressor gene p53, often referred to as the "guardian of the genome", is 
required for checkpoint control during cell cycle progression (Meikrantz and Schlegal, 1995). 
During the cell cycle, DNA damage is detected at two checkpoints: the Gi-S phase and the G2-M 
phase (Merritt et al., 1997). Depending on the type and extent of DNA damage, p53 can initiate 
one of three pathways: cell cycle arrest at a checkpoint, repair of the damaged cell, or apoptosis 
of the cell (Elmore, 2007; Figure 1). However, in cancer cells, these pathways are defective and 
therefore the cells lack the ability to detect damage and thereby initiate an appropriate response 
as needed. This can eventually lead to genetic instability and uncontrolled cell growth resulting 
in tumors (Elmore, 2007). When DNA damage occurs, the kinase ATM is the first protein to be 
phosphorylated. Once phosphorylated, ATM can activate various downstream gene products, 
including p53, SMC1, NBS1, and Histone H2A.X (Burma et al., 2001; Figure 1). One of these 
factors, the H2A.X, is a key indicator of the levels of DNA damage, specifically double-stranded 
DNA breaks. As the level of DNA damage rises, the level of phosphorylated H2A.X also rises 
and begins to aggregate at locations where damage is detected (Burma et al., 2001). H2A.X can 
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then activate various downstream factors such as p53 to initiate repair of the damaged cell. The 
major role of the checkpoint controlling entry into S phase of the cell cycle is to prevent 
damaged cells from replicating damaged DNA. This is controlled via the p53 protein, which 
induces either cell cycle arrest in Gi or cause apoptosis (Merritt et al., 1997; Figure 1). Although 
the p53-mediated Gi arrest has been commonly studied, p53 regulation at the G2 phase has also 
been found to occur (Guillouf et al., 1995). 
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Figure 1. A proposed pathway by which ATM 
and H2A.X activate p53 to induce DNA repair, 
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cell cycle arrest, and apoptosis    . 
1.1.4    Bcl-2 protein and cancer 
Bcl-2 is a member of the much larger Bcl-2 family that controls apoptosis by regulating 
the proteins responsible for mitochondrial membrane permeability (Jin and El-Deiry, 2005). The 
Bcl-2 family consists of two protein sub-groups, the pro-apoptotic proteins and the anti-apoptotic 
tiiimiMffiMiMiffiMromnTiTinnffiw 
proteins. Bcl-2 is an anti-apoptotic family member that acts by forming a complex with pro- 
apoptotic proteins such as Bax, thereby sequestering them and inhibiting their insertion into the 
mitochondrial membrane (Adams and Cory, 2007). When an apoptotic signal is received, Bcl-2 
is supposed to release Bax, allowing Bax to insert into the mitochondria and release cytochrome 
C into the cytoplasm, promoting caspase activation and cell death (Figure 2). However, in cancer 
cells, apoptosis is often prevented due to an up-regulation of anti-apoptotic Bcl-2 proteins or 
dysfunction of pro-apoptotic proteins (Adams and Cory, 2007). The ratio of anti-apoptotic Bcl-2 
proteins is often very high in various hematologic malignancies such as non-Hodgkin's 
lymphoma (Jin and El-Deiry, 2005). Preclinical studies have shown that Bcl-2 serves a major 
role in regulating the intrinsic apoptotic signaling pathway by binding pro-apoptotic molecules 
and thereby preventing them from carrying out their specific functions within the mitochondria 
(Jin and El-Deiry, 2005). Therefore, Bcl-2 is capable of promoting the survival of regulatory B- 
cells by inhibiting apoptosis, which can result in chemotherapy resistance in various hematologic 
cancers (Adams and Cory, 2007). 
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Figure 2. A proposed pathway by which Bcl-2 
and Bax interact to induce apoptosis after cell 
damage is detected   . 
1.1.5    Aims of our Study 
The goals of this study were to determine the anti-proliferative and apoptotic effects of 
curcumin on MDA-MB 468 cells and to determine how curcumin affects the abundance of two 
specific apoptotic and cell cycle proteins: p53 and Bcl-2. We hypothesized a dose-dependent 
increase in cell death and a dose-dependent decrease in cell proliferation following 
curcumin treatment. We also hypothesized that curcumin would cause an up-regulation of 
p53 expression and a down-regulation of Bcl-2 activation (Figure 3). 
I 
DNA DAMAi 
Figure 3. Curcumin is hypothesized to cause DNA damage. 
The p53 pathway on the left begins with the activation of 
the kinase ATM as soon as DNA damage is detected. ATM 
will then phosphorylate the H2A.X protein (the double- 
strand break detector) causing an up-regulation of p53. The 
pathway on the right shows the Bcl-2 pathway. We predict 
curcumin to cause an increase in inactive Bcl-2 via 
phosphorylation, which will cause a conformational change 
and prevent Bax (a pro-apoptotic protein) to be bound to 
Bcl-2. This will allow Bax to form its own complex and 
activate caspases that will eventually lead to apoptosis. 
Chapter II 
Materials and Methods 
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Materials 
MDA-MB-468 breast adenocarcinoma cells were obtained from the American Type Cell 
Culture Collection (ATCC, Manassas, VA) and cultured in Leibovitz L-15 Media (Hyclone, 
Logan, UT) supplemented with 10% Fetal Bovine Sera (Atlanta Biologicals, Atlanta, GA) and 
1% Anitbiotic/antimycotic (Invitrogen, Grand Island, NY). MDA-MB-468 were grown at 37°C 
in a free gas exchange with atmospheric air. Curcumin (diferuloylmethane) and dimethyl 
sulfoxide (DMSO) were obtained from GE Healthcare Bio-Sciences (Pittsburgh, Pennsylvania). 
Annexin V and Dead Cell kit, Multi-Colored DNA Damage kit, and Bcl-2 Dual Detection kit 
were obtained from EMD Millipore Muse® (Billerica, Massachusetts). 
Cell Treatment 
Curcumin was first dissolved in DMSO (Sigma-Aldrich, St. Louis, MS) as a 10 mM 
stock solution and subsequently diluted in L-15 culture medium. Medium containing the same 
amount of DMSO was used as control at concentrations not exceeding the 0.1% v/v of the 
culture medium. Cells were incubated with curcumin at 0, 25, 50, and 100 uM, at three time 
points namely 24, 48, and 72 h. Briefly, MDA-MB-468 cells were inoculated at a density of 
2xl04 cells/well in a 12-wellplate for 72 h in 1 mL of L-15 medium. The culture supernatant was 
then removed and medium containing the above mentioned curcumin concentrations were added 
to cells and subsequently incubated for 24 h. 
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Figure 4. Cell treatment in 12-well plate. 
Annexin V and Dead Cell Kit 
This kit was used to determine percentage of cell death and proliferation. Cells were 
detached from the plate using a cell scraper and 100 uL of the cell suspension was placed into 
microcentrifuge tubes. Next, 100 uL of Muse Annexin V and Dead Cell Reagent was added into 
each tube. Samples were mixed thoroughly using a vortex at medium speed for about 3 to 5 
seconds. Finally, samples were stained for 20 min. at RT and analyzed using a Muse Cell 
Analyzer. 
Multi-Color DNA Damage Kit 
This kit was used to indirectly measure p53 expression. Briefly, cells were centrifuged at 
300 x g for 5 min. and washed once with IX PBS. Following centrifugation, cells were fixed 
with Fixation Buffer and permeabilized with Permeabilization Buffer for 10 min. on ice and 
washed with PBS as before. Cells were then treated with 10 uL of the Anti-phospho-ATM /Anti- 
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phospho-Histone H2A.X antibody cocktail. Samples were incubated in the dark for 30 min. at 
room temperature. Following incubation, cells were centrifuged at 300 x g for 5 min. and washed 
with IX Assay Buffer. Cells were then resuspended in 200 uL IX Assay Buffer and analyzed on 
a Muse Cell Analyzer. 
Bcl-2 Dual Detection Kit 
This kit was used to measure percentage of Bcl-2 protein activation. The procedure for 
this assay was exactly as the Multi-Color DNA Damage Kit, except cells were fixed and 
permeabilized for 5 min. and an antibody cocktail consisting of a phospho-specific anti-phospho- 
Bcl-2 +anti-Bcl-2 was used. 
Statistical Analyses 
The independent variable in the experiment was the curcumin concentration. The 
dependent variables were percentage of cell death, cell proliferation, DNA Double-strand breaks, 
and Bcl-2 inactivation. Data were expressed as means ± 1 SD. Statistical significance of 
differences between means was determined by 1-way ANOVA and a Least Significant 
Differences (LSD) Post-Hoc test. Probability values of p < 0.05 were considered statistically 
significant. 
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Figure 5. Results of a sample acquired using 
Muse® Cell Analyzer for the Multi-Color 
DNA Damage assay. The lower left quadrant 
shows percentage of negative cells that had 
no DNA damage. The lower right quadrant 
shows percentage of H2A.X- activated cells. 
The upper left shows percentage of ATM- 
activated cells, and the upper right indicates 
percentage of DNA double-strand breaks via 
dual activation of both ATM and H2A.X. 
This is the quadrant we were interested in 
since p53 expression involves the 
phosphorylation of both ATM and H2A.X. 
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Figure 6. Results of a sample acquired using 
Muse® Cell Analyzer for the Bcl-2 
Activation Assay. The lower left quadrant 
shows percentage of non-expressing cells. 
The upper right quadrant indicates 
percentage of activated cells via 
phosphorylation, and the upper left shows 
percentage of inactivated cells. This is the 
quadrant we were interested in since 
inactivation of Bcl-2 allows Bax to form a 
complex where it can induces apoptosis in 
the cells via activation of a series of 
downstream proteins. 
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Control 25 50 100 
Curcumin Concentration (uM) 
Figure 7. Effect of curcumin on average (+/- 1 S.E) death of MDA- 
MB 468 cells. The x-axis corresponds to the different 
concentrations of curcumin measured in uM (0, 25, 50, and 100) 
and the y-axis corresponds to the total cell death percentage. Cells 
were treated with the above curcumin concentrations for 24 h. Cell 
death was determined using the Annexin V Dead Cell kit and a 
Muse Cell Analyzer. 
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Figure 8. Effect of curcumin on average (+/- 1 S.E) proliferation 
of MDA-MB 468 cells. The x-axis corresponds to the different 
concentrations of curcumin measured in uM (0, 25, 50, and 100) 
and the y-axis corresponds to the total cell proliferation in 
cells/mL. Cells were treated with the above curcumin 
concentrations for 24 h. Proliferation was determined using the 
Annexin V Dead Cell kit and a Muse Cell Analyzer. 
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Control 
Curcumin Concentration(uM) 
Figure 9. Effect of curcumin on average (+/- 1 S.E) p53 expression 
in MDA-MB 468 cells. Cells were exposed to 0, 25, 50, and 100 uM 
curcumin for 24 hours to induce DNA damage, and then stained with 
both anti-phospho-Histone H2A.X and anti-phospho-ATM 
antibodies in multiplex. Indirect p53 expression was determined via 
percentage of double -strand breaks in DNA as a result of 
phosphorylation of the ATM and H2A.X proteins as seen on the y- 
axis. Samples were acquired using the Muse™ Cell Analyzer. 
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Control 
Curcumin Concentration (uM) 
Figure 10. Effect of curcumin on average (+/- 1 S.E) expression of 
inactive Bcl-2 in MDA-MB 468 cells. Cells were exposed to 0, 25, 
50, and 100 uM curcumin for 24 hours to induce DNA damage, 
and then stained with both a phospho-specific anti-phospho-Bcl-2 
and anti-Bcl-2 antibodies in multiplex. Samples were acquired 
using the Muse™ Cell Analyzer. 
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Discussion 
Curcumin caused a significant dose-dependent increase in cell death at the different 
concentrations (1-way ANOVA, F3>32=4.119, P=0.014; Figure 7) with the 100 uM concentration 
having a significantly higher amount of cell death compared to the control, 25 uM, and 50 uM . 
Curcumin was hypothesized to induce a dose-dependent decrease in cell proliferation. However, 
our data shows that curcumin caused a dose-dependent increase in cell proliferation when 
compared to the control (1-way ANOVA, F3,32=6.005, P=0.002; Figure 8) which is contrary to 
the hypothesis. Hence, our data does not support the hypothesis. A possible explanation for this 
difference may be as follows. Since curcumin is derived from turmeric, a root plant containing 
starch, the cells could be using this starch as an additional carbon source to provide the energy 
needed to grow and reproduce. 
Our results also suggest that curcumin did not cause an increase in p53 expression 
because there was no significant difference in curcumin-induced double strand breaks (DSB) in 
DNA (1-way ANOVA, F3)32=1.505, P=0.232; Figure 9). The connection between DSB and p53 
is in the pathway involving activation of ATM which detects DNA damage (Figure 1). When 
DNA damage occurs (curcumin-induced DSB) ATM phosphorylates the H2A.X protein which 
responds to DSBs. H2A.X then activates p53 to induce apoptosis or DNA repair. Therefore, an 
increase in DSBs should indirectly correspond to an increase in p53 expression. Furthermore, 
this increase in p53 expression should allow for p53 to initiate apoptosis because of a dose- 
dependent increase in DNA damage. Although a dose-dependent increase in DSB was shown in 
both the 25uM and 50 uM curcumin treated samples relative to the control, the data was not 
statistically significant, p=0.232. Therefore, more trials need to be conducted in order to get a 
tflftMlHtltffflil 
18 
significant result and prove the proposed pathway. In a study conducted by Rowe et al. in 2009, 
they found that following curcumin treatment, phosphorylation occurred at ATM-specific sites 
on the breast cancer (BRCA) 1 gene, which was consistent with the activation of a DNA damage 
response. In addition, phosphorylated H2A.X was detected in cells treated with curcumin, 
indicating that the type of damage induced by curcumin was a DNA double strand break (Rowe 
et al., 2009). 
Curcumin did not cause a significant dose-dependent increase in inactive Bcl-2 
expression as previously hypothesized (1-way ANOVA, F3,2o=0.102, P=0.958; Figure 10). It is 
known that curcumin induces apoptosis via suppression of anti-apoptotic Bcl-2, allowing the 
release of cytochrome c into the cytosol and activation of caspases (Anto et al., 2002; Rao et al., 
2011). Inactivation (phosphorylation) of Bcl-2 allows the Bax protein to form a complex within 
the mitochondrial membrane that induces cell death. Although there was a slight increase in 
phosphorylated Bcl-2, it was not significant, p=0.958. Hence, more trials need to be conducted in 
order to see a more accurate reflection of the pathway taken by these cells to reach apoptosis. 
Although there was no significant increase in p53 expression or Bcl-2 inactivation, there 
was a significant increase in both cell death and proliferation. Hence, future studies can look at 
the rates of curcumin-induced cell death versus cell growth in the cells. Also, the cells can be 
treated with curcumin for longer periods of time (24, 48, and 72 hours) which may result in 
curcumin inducing a higher percentage of DNA damage thereby decreasing the amount of cell 
growth. Also, curcumin's effects on p53 and Bcl-2 proteins should be studied on other 
carcinomas since these two oncoproteins play vital roles in cellular pathways. 
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